These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31949778)

  • 41. The occurrence and frequency of genomic mutations that mediate Isoniazid and Rifampicin resistance in
    Kumwenda GP; Chipungu G; Sloan DJ; Kaimila Y; Chiumya K; Pangani H
    Malawi Med J; 2018 Mar; 30(1):1-5. PubMed ID: 29868151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular Basis of Resistance to First-Line Drugs of
    Florou Z; Mavroidi A; Vatidis G; Daniil Z; Gourgoulianis K; Petinaki E
    Microb Drug Resist; 2021 Oct; 27(10):1389-1396. PubMed ID: 33877884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutations in
    Solari L; Santos-Lazaro D; Puyen ZM
    Int J Microbiol; 2020; 2020():8253546. PubMed ID: 32322275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Large-scale statistical analysis of Mycobacterium tuberculosis genome sequences identifies compensatory mutations associated with multi-drug resistance.
    Billows N; Phelan J; Xia D; Peng Y; Clark TG; Chang YM
    Sci Rep; 2024 May; 14(1):12312. PubMed ID: 38811658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan.
    Farooqi JQ; Khan E; Alam SM; Ali A; Hasan Z; Hasan R
    J Pak Med Assoc; 2012 Aug; 62(8):767-72. PubMed ID: 23862246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genomic Analysis Identifies Mutations Concerning Drug-Resistance and Beijing Genotype in Multidrug-Resistant
    Wan L; Liu H; Li M; Jiang Y; Zhao X; Liu Z; Wan K; Li G; Guan CX
    Front Microbiol; 2020; 11():1444. PubMed ID: 32760357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
    Rockwood N; Sirgel F; Streicher E; Warren R; Meintjes G; Wilkinson RJ
    J Infect Dis; 2017 Sep; 216(6):632-640. PubMed ID: 28934422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis by high-resolution melting analysis.
    Ong DC; Yam WC; Siu GK; Lee AS
    J Clin Microbiol; 2010 Apr; 48(4):1047-54. PubMed ID: 20164280
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India.
    Munir A; Kumar N; Ramalingam SB; Tamilzhalagan S; Shanmugam SK; Palaniappan AN; Nair D; Priyadarshini P; Natarajan M; Tripathy S; Ranganathan UD; Peacock SJ; Parkhill J; Blundell TL; Malhotra S
    Sci Rep; 2019 Jul; 9(1):10283. PubMed ID: 31311987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The Spectrum of Mutations in Genes Associated with Resistance to Rifampicin, Isoniazid, and Fluoroquinolones in the Clinical Strains of M. tuberculosis Reflects the Transmissibility of Mutant Clones].
    Ergeshov A; Andreevskaya SN; Larionova EE; Smirnova TG; Chernousova LN
    Mol Biol (Mosk); 2017; 51(4):595-602. PubMed ID: 28900077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance.
    Phelan J; Coll F; McNerney R; Ascher DB; Pires DE; Furnham N; Coeck N; Hill-Cawthorne GA; Nair MB; Mallard K; Ramsay A; Campino S; Hibberd ML; Pain A; Rigouts L; Clark TG
    BMC Med; 2016 Mar; 14():31. PubMed ID: 27005572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Whole-genome sequencing and single nucleotide polymorphisms in multidrug-resistant clinical isolates of Mycobacterium tuberculosis from the Philippines.
    Roa MB; Tablizo FA; Morado EKD; Cunanan LF; Uy IDC; Ng KCS; Manalastas-Cantos KG; Reyes JM; Ganchua SKC; Ang CF; Kato-Maeda M; Cattamanchi A; Karaoz U; Destura RV; Lluisma AO
    J Glob Antimicrob Resist; 2018 Dec; 15():239-245. PubMed ID: 30130640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan.
    Ali A; Hasan Z; McNerney R; Mallard K; Hill-Cawthorne G; Coll F; Nair M; Pain A; Clark TG; Hasan R
    PLoS One; 2015; 10(2):e0117771. PubMed ID: 25719196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families.
    Kasule GW; Kateete DP; Joloba ML
    BMC Infect Dis; 2016 Apr; 16():173. PubMed ID: 27097724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Five-year microevolution of a multidrug-resistant Mycobacterium tuberculosis strain within a patient with inadequate compliance to treatment.
    Fernandez Do Porto DA; Monteserin J; Campos J; Sosa EJ; Matteo M; Serral F; Yokobori N; Benevento AF; Poklepovich T; Pardo A; Wainmayer I; Simboli N; Castello F; Paul R; Martí M; López B; Turjanski A; Ritacco V
    BMC Infect Dis; 2021 Apr; 21(1):394. PubMed ID: 33926375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pyrosequencing for rapid detection of tuberculosis resistance to Rifampicin and Isoniazid in Syrian and Lebanese clinical isolates.
    Hamze M; Ismail MB; Rahmo AK; Dabboussi F
    Int J Mycobacteriol; 2015 Sep; 4(3):228-32. PubMed ID: 27649870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular Characterization of Mutations in Isoniazid- and Rifampicin-Resistant Mycobacterium tuberculosis Isolated in Thailand.
    Rudeeaneksin J; Phetsuksiri B; Nakajima C; Fukushima Y; Suthachai W; Tipkrua N; Suthum K; Jekloh N; Bunchoo S; Srisungngam S; Klayut W; Hamada S; Suzuki Y
    Jpn J Infect Dis; 2023 Jan; 76(1):39-45. PubMed ID: 36047179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [DNA mutations associated to rifampicin or isoniazid resistance in M. tuberculosis clinical isolates from Sonora, Mexico].
    Bolado-Martínez E; Pérez-Mendoza A; Alegría-Morquecho FM; Candia-Plata Mdel C; Aguayo-Verdugo Mdel R; Alvarez-Hernández G
    Salud Publica Mex; 2012; 54(2):167-70. PubMed ID: 22535176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Nimri L; Samara H; Batchoun R
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):321-7. PubMed ID: 21569121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutation profiling for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates.
    Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
    J Antimicrob Chemother; 2015 Dec; 70(12):3214-21. PubMed ID: 26311839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.